Free Access
Med Sci (Paris)
Volume 23, Number 3, Mars 2007
Page(s) 257 - 258
Section Nouvelles
Published online 15 March 2007
  1. Lake RA, van der Most RG. A better way for a cancer cell to die. N Engl J Med 2006; 354 : 2503–4. [Google Scholar]
  2. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6 : 715–27. [Google Scholar]
  3. Zitvogel L, Casares N, Pequignot MO, Chaput N, Albert ML, Kroemer G. Immune response against dying tumor cells. Adv Immunol 2004; 84 : 131–79. [Google Scholar]
  4. Casares N, Pequignot MO, Tesniere A, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202 : 1691–701. [Google Scholar]
  5. Obeid M, Tesniere A, Ghiringhelli F, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2006; 13 : 54–61. [Google Scholar]
  6. Krause KH, Michalak M. Calreticulin. Cell 1997; 88 : 439–43. [Google Scholar]
  7. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5 : 103–14. [Google Scholar]
  8. Bedard K, Szabo E, Michalak M, Opas M. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 2005; 245 : 91–121. [Google Scholar]
  9. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005; 123 : 321–34. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.